{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T05:58:48Z","timestamp":1790402328598,"version":"4.1.0"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2012,2,14]],"date-time":"2012-02-14T00:00:00Z","timestamp":1329177600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0\/"},{"start":{"date-parts":[[2012,2,14]],"date-time":"2012-02-14T00:00:00Z","timestamp":1329177600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                        <jats:title>Introduction<\/jats:title>\n                        <jats:p>Male breast cancer (MBC) is a rare and inadequately characterized disease. The aim of the present study was to characterize MBC tumors transcriptionally, to classify them into comprehensive subgroups, and to compare them with female breast cancer (FBC).<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Methods<\/jats:title>\n                        <jats:p>A total of 66 clinicopathologically well-annotated fresh frozen MBC tumors were analyzed using Illumina Human HT-12 bead arrays, and a tissue microarray with 220 MBC tumors was constructed for validation using immunohistochemistry. Two external gene expression datasets were used for comparison purposes: 37 MBCs and 359 FBCs.<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Results<\/jats:title>\n                        <jats:p>Using an unsupervised approach, we classified the MBC tumors into two subgroups, luminal M1 and luminal M2, respectively, with differences in tumor biological features and outcome, and which differed from the intrinsic subgroups described in FBC. The two subgroups were recapitulated in the external MBC dataset. Luminal M2 tumors were characterized by high expression of immune response genes and genes associated with estrogen receptor (ER) signaling. Luminal M1 tumors, on the other hand, despite being ER positive by immunohistochemistry showed a lower correlation to genes associated with ER signaling and displayed a more aggressive phenotype and worse prognosis. Validation of two of the most differentially expressed genes, class 1 human leukocyte antigen (<jats:italic>HLA<\/jats:italic>) and the metabolizing gene <jats:italic>N<\/jats:italic>-acetyltransferase-1 (<jats:italic>NAT1<\/jats:italic>), respectively, revealed significantly better survival associated with high expression of both markers (HLA, hazard ratio (HR) 3.6, <jats:italic>P<\/jats:italic> = 0.002; NAT1, HR 2.5, <jats:italic>P<\/jats:italic> = 0.033). Importantly, NAT1 remained significant in a multivariate analysis (HR 2.8, <jats:italic>P<\/jats:italic> = 0.040) and may thus be a novel prognostic marker in MBC.<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Conclusions<\/jats:title>\n                        <jats:p>We have detected two unique and stable subgroups of MBC with differences in tumor biological features and outcome. They differ from the widely acknowledged intrinsic subgroups of FBC. As such, they may constitute two novel subgroups of breast cancer, occurring exclusively in men, and which may consequently require novel treatment approaches. Finally, we identified NAT1 as a possible prognostic biomarker for MBC, as suggested by NAT1 positivity corresponding to better outcome.<\/jats:p>\n                     <\/jats:sec>","DOI":"10.1186\/bcr3116","type":"journal-article","created":{"date-parts":[[2012,2,14]],"date-time":"2012-02-14T17:14:20Z","timestamp":1329239660000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":111,"title":["Gene expression profiling of primary male breast cancers reveals two unique subgroups and identifies N-acetyltransferase-1 (NAT1) as a novel prognostic biomarker"],"prefix":"10.1186","volume":"14","author":[{"given":"Ida","family":"Johansson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecilia","family":"Nilsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pontus","family":"Berglund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Lauss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Ringn\u00e9r","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u00e5kan","family":"Olsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lena","family":"Luts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edith","family":"Sim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sten","family":"Thorstensson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Louise","family":"Fj\u00e4llskog","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingrid","family":"Hedenfalk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,2,14]]},"reference":[{"key":"2927_CR1","first-page":"532","volume":"49","author":"G Engholm","year":"2009","unstructured":"Engholm G, Ferlay J, Christensen N, Bray F, Gjerstorff ML, Klint \u00c5, K\u00f8tlum JE, \u00d3lafsd\u00f3ttir E, Pukkala E, Storm HH: NORDCAN: Cancer Incidence, Mortality, Prevalence and Prediction in the Nordic Countries. Acta Oncologica. 2009, 49: 532-544.","journal-title":"Acta Oncologica"},{"key":"2927_CR2","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1634\/theoncologist.10-7-471","volume":"10","author":"SH Giordano","year":"2005","unstructured":"Giordano SH: A review of the diagnosis and management of male breast cancer. Oncologist. 2005, 10: 471-479. 10.1634\/theoncologist.10-7-471.","journal-title":"Oncologist"},{"key":"2927_CR3","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/s10549-006-9356-z","volume":"103","author":"A Agrawal","year":"2007","unstructured":"Agrawal A, Ayantunde AA, Rampaul R, Robertson JF: Male breast cancer: a review of clinical management. Breast Cancer Res Treat. 2007, 103: 11-21. 10.1007\/s10549-006-9356-z.","journal-title":"Breast Cancer Res Treat"},{"key":"2927_CR4","doi-asserted-by":"publisher","first-page":"2114","DOI":"10.1200\/JCO.2009.25.5729","volume":"28","author":"LA Korde","year":"2010","unstructured":"Korde LA, Zujewski JA, Kamin L, Giordano S, Domchek S, Anderson WF, Bartlett JM, Gelmon K, Nahleh Z, Bergh J, Cutuli B, Pruneri G, McCaskill-Stevens W, Gralow J, Hortobagyi G, Cardoso F: Multidisciplinary meeting on male breast cancer: summary and research recommendations. J Clin Oncol. 2010, 28: 2114-2122. 10.1200\/JCO.2009.25.5729.","journal-title":"J Clin Oncol"},{"key":"2927_CR5","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1023\/B:BREA.0000019953.92921.7e","volume":"84","author":"C Rudlowski","year":"2004","unstructured":"Rudlowski C, Friedrichs N, Faridi A, Fuzesi L, Moll R, Bastert G, Rath W, Buttner R: Her-2\/neu gene amplification and protein expression in primary male breast cancer. Breast Cancer Res Treat. 2004, 84: 215-223. 10.1023\/B:BREA.0000019953.92921.7e.","journal-title":"Breast Cancer Res Treat"},{"key":"2927_CR6","unstructured":"Nilsson C, Johansson I, Ahlin C, Thorstensson s, Amini RM, Holmqvist M, Hedenfalk I, Fj\u00e4llskog M-L: Molecular subtyping of male breast cancer using alternative definitions and its prognostic impact. Submitted,"},{"key":"2927_CR7","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1007\/s10549-008-0194-z","volume":"116","author":"L Ottini","year":"2009","unstructured":"Ottini L, Rizzolo P, Zanna I, Falchetti M, Masala G, Ceccarelli K, Vezzosi V, Gulino A, Giannini G, Bianchi S, Sera F, Palli D: BRCA1\/BRCA2 mutation status and clinical-pathologic features of 108 male breast cancer cases from Tuscany: a population-based study in central Italy. Breast Cancer Res Treat. 2009, 116: 577-586. 10.1007\/s10549-008-0194-z.","journal-title":"Breast Cancer Res Treat"},{"key":"2927_CR8","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1093\/jnci\/djn329","volume":"100","author":"LA Brinton","year":"2008","unstructured":"Brinton LA, Richesson DA, Gierach GL, Lacey JV, Park Y, Hollenbeck AR, Schatzkin A: Prospective evaluation of risk factors for male breast cancer. J Natl Cancer Inst. 2008, 100: 1477-1481. 10.1093\/jnci\/djn329.","journal-title":"J Natl Cancer Inst"},{"key":"2927_CR9","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.3109\/0284186X.2011.602114","volume":"50","author":"C Nilsson","year":"2011","unstructured":"Nilsson C, Holmqvist M, Bergkvist L, Hedenfalk I, Lambe M, Fj\u00e4llskog M-L: Similarities and differences in the characteristics and treatment of breast cancer in men and women-a population based study (Sweden). Acta Oncol. 2011, 50: 1083-1088. 10.3109\/0284186X.2011.602114.","journal-title":"Acta Oncol"},{"key":"2927_CR10","doi-asserted-by":"publisher","first-page":"1733","DOI":"10.1002\/cncr.21353","volume":"104","author":"WF Anderson","year":"2005","unstructured":"Anderson WF, Devesa SS: In situ male breast carcinoma in the Surveillance, Epidemiology, and End Results database of the National Cancer Institute. Cancer. 2005, 104: 1733-1741. 10.1002\/cncr.21353.","journal-title":"Cancer"},{"issue":"2","key":"2927_CR11","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1111\/j.1349-7006.2008.01032.x","volume":"100","author":"L Thalib","year":"2008","unstructured":"Thalib L, Hall P: Survival of male breast cancer patients: Population-based cohort study. Cancer Sci. 2008, 100 (2): 292-295.","journal-title":"Cancer Sci"},{"key":"2927_CR12","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1002\/cncr.20312","volume":"101","author":"SH Giordano","year":"2004","unstructured":"Giordano SH, Cohen DS, Buzdar AU, Perkins G, Hortobagyi GN: Breast carcinoma in men: a population-based study. Cancer. 2004, 101: 51-57. 10.1002\/cncr.20312.","journal-title":"Cancer"},{"key":"2927_CR13","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1159\/000153894","volume":"31","author":"SH Giordano","year":"2008","unstructured":"Giordano SH: Male breast cancer: it's time for evidence instead of extrapolation. Onkologie. 2008, 31: 505-506.","journal-title":"Onkologie"},{"key":"2927_CR14","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1007\/s10549-010-1262-8","volume":"129","author":"I Johansson","year":"2011","unstructured":"Johansson I, Nilsson C, Berglund P, Strand C, Jonsson G, Staaf J, Ringner M, Nevanlinna H, Barkardottir RB, Borg A, Olsson H, Luts L, Fjallskog ML, Hedenfalk I: High-resolution genomic profiling of male breast cancer reveals differences hidden behind the similarities with female breast cancer. Breast Cancer Res Treat. 2011, 129: 747-760. 10.1007\/s10549-010-1262-8.","journal-title":"Breast Cancer Res Treat"},{"key":"2927_CR15","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1007\/s10549-010-1015-8","volume":"127","author":"M Callari","year":"2011","unstructured":"Callari M, Cappelletti V, De Cecco L, Musella V, Miodini P, Veneroni S, Gariboldi M, Pierotti MA, Daidone MG: Gene expression analysis reveals a different transcriptomic landscape in female and male breast cancer. Breast Cancer Res Treat. 2011, 127: 601-610. 10.1007\/s10549-010-1015-8.","journal-title":"Breast Cancer Res Treat"},{"key":"2927_CR16","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1186\/1471-2407-10-109","volume":"10","author":"U Lehmann","year":"2010","unstructured":"Lehmann U, Streichert T, Otto B, Albat C, Hasemeier B, Christgen H, Schipper E, Hille U, Kreipe HH, Langer F: Identification of differentially expressed microRNAs in human male breast cancer. BMC Cancer. 2010, 10: 109-10.1186\/1471-2407-10-109.","journal-title":"BMC Cancer"},{"key":"2927_CR17","doi-asserted-by":"publisher","first-page":"R58","DOI":"10.1186\/bcr2348","volume":"11","author":"M Fassan","year":"2009","unstructured":"Fassan M, Baffa R, Palazzo JP, Lloyd J, Crosariol M, Liu CG, Volinia S, Alder H, Rugge M, Croce CM, Rosenberg A: MicroRNA expression profiling of male breast cancer. Breast Cancer Res. 2009, 11: R58-10.1186\/bcr2348.","journal-title":"Breast Cancer Res"},{"issue":"3","key":"2927_CR18","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1155\/2010\/468280","volume":"33","author":"S Tommasi","year":"2010","unstructured":"Tommasi S, Mangia A, Iannelli G, Chiarappa P, Rossi E, Ottini L, Mottolese M, Zoli W, Zuffardi O, Paradiso A: Gene copy number variation in male breast cancer by aCGH. Anal Cell Pathol (Amst). 2010, 33 (3): 113-119.","journal-title":"Anal Cell Pathol (Amst)"},{"key":"2927_CR19","doi-asserted-by":"publisher","first-page":"10869","DOI":"10.1073\/pnas.191367098","volume":"98","author":"T Sorlie","year":"2001","unstructured":"Sorlie T, Perou CM, Tibshirani R, Aas T, Geisler S, Johnsen H, Hastie T, Eisen MB, van de Rijn M, Jeffrey SS, Thorsen T, Quist H, Matese JC, Brown PO, Botstein D, Eystein Lonning P, Borresen-Dale AL: Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci USA. 2001, 98: 10869-10874. 10.1073\/pnas.191367098.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2927_CR20","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1038\/35021093","volume":"406","author":"CM Perou","year":"2000","unstructured":"Perou CM, Sorlie T, Eisen MB, van de Rijn M, Jeffrey SS, Rees CA, Pollack JR, Ross DT, Johnsen H, Akslen LA, Fluge O, Pergamenschikov A, Williams C, Zhu SX, Lonning PE, Borresen-Dale AL, Brown PO, Botstein D: Molecular portraits of human breast tumours. Nature. 2000, 406: 747-752. 10.1038\/35021093.","journal-title":"Nature"},{"key":"2927_CR21","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1186\/1471-2164-7-96","volume":"7","author":"Z Hu","year":"2006","unstructured":"Hu Z, Fan C, Oh DS, Marron JS, He X, Qaqish BF, Livasy C, Carey LA, Reynolds E, Dressler L, Nobel A, Parker J, Ewend MG, Sawyer LR, Wu J, Liu Y, Nanda R, Tretiakova M, Ruiz Orrico A, Dreher D, Palazzo JP, Perreard L, Nelson E, Mone M, Hansen H, Mullins M, Quackenbush JF, Ellis MJ, Olopade OI, Bernard PS, Perou CM: The molecular portraits of breast tumors are conserved across microarray platforms. BMC Genomics. 2006, 7: 96-10.1186\/1471-2164-7-96.","journal-title":"BMC Genomics"},{"key":"2927_CR22","doi-asserted-by":"publisher","first-page":"R42","DOI":"10.1186\/bcr2596","volume":"12","author":"G Jonsson","year":"2010","unstructured":"Jonsson G, Staaf J, Vallon-Christersson J, Ringner M, Holm K, Hegardt C, Gunnarsson H, Fagerholm R, Strand C, Agnarsson BA, Kilpivaara O, Luts L, Heikkila P, Aittomaki K, Blomqvist C, Loman N, Malmstrom P, Olsson H, Johannsson OT, Arason A, Nevanlinna H, Barkardottir RB, Borg A: Genomic subtypes of breast cancer identified by array comparative genomic hybridization display distinct molecular and clinical characteristics. Breast Cancer Res. 2010, 12: R42-10.1186\/bcr2596.","journal-title":"Breast Cancer Res"},{"key":"2927_CR23","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1186\/1471-2105-10-330","volume":"10","author":"J Vallon-Christersson","year":"2009","unstructured":"Vallon-Christersson J, Nordborg N, Svensson M, Hakkinen J: BASE--2nd generation software for microarray data management and analysis. BMC Bioinformatics. 2009, 10: 330-10.1186\/1471-2105-10-330.","journal-title":"BMC Bioinformatics"},{"key":"2927_CR24","unstructured":"The R Project for Statistical Computing. [http:\/\/www.r-project.org]"},{"key":"2927_CR25","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1093\/biostatistics\/kxj037","volume":"8","author":"WE Johnson","year":"2007","unstructured":"Johnson WE, Li C, Rabinovic A: Adjusting batch effects in microarray expression data using empirical Bayes methods. Biostatistics. 2007, 8: 118-127.","journal-title":"Biostatistics"},{"key":"2927_CR26","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1093\/nar\/30.1.207","volume":"30","author":"R Edgar","year":"2002","unstructured":"Edgar R, Domrachev M, Lash AE: Gene Expression Omnibus: NCBI gene expression and hybridization array data repository. Nucleic Acids Res. 2002, 30: 207-210. 10.1093\/nar\/30.1.207.","journal-title":"Nucleic Acids Res"},{"issue":"6","key":"2927_CR27","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1214\/009053604000000823","volume":"32","author":"H Shimodaira","year":"2004","unstructured":"Shimodaira H: Approximately unbiased tests of regions using multistep-multiscale bootstrap resampling. Ann Stat. 2004, 32 (6): 26-","journal-title":"Ann Stat"},{"key":"2927_CR28","doi-asserted-by":"publisher","first-page":"3463","DOI":"10.1158\/0008-5472.CAN-09-4213","volume":"70","author":"D Lindgren","year":"2010","unstructured":"Lindgren D, Frigyesi A, Gudjonsson S, Sjodahl G, Hallden C, Chebil G, Veerla S, Ryden T, Mansson W, Liedberg F, Hoglund M: Combined gene expression and genomic profiling define two intrinsic molecular subtypes of urothelial carcinoma and gene signatures for molecular grading and outcome. Cancer Res. 2010, 70: 3463-3472. 10.1158\/0008-5472.CAN-09-4213.","journal-title":"Cancer Res"},{"key":"2927_CR29","doi-asserted-by":"publisher","first-page":"e17","DOI":"10.1093\/nar\/gkp942","volume":"38","author":"NL Barbosa-Morais","year":"2010","unstructured":"Barbosa-Morais NL, Dunning MJ, Samarajiwa SA, Darot JF, Ritchie ME, Lynch AG, Tavare S: A re-annotation pipeline for Illumina BeadArrays: improving the interpretation of gene expression data. Nucleic Acids Res. 2010, 38: e17-10.1093\/nar\/gkp942.","journal-title":"Nucleic Acids Res"},{"key":"2927_CR30","doi-asserted-by":"publisher","first-page":"P3","DOI":"10.1186\/gb-2003-4-5-p3","volume":"4","author":"G Dennis Jr","year":"2003","unstructured":"Dennis G, Sherman BT, Hosack DA, Yang J, Gao W, Lane HC, Lempicki RA: DAVID: Database for Annotation, Visualization, and Integrated Discovery. Genome Biol. 2003, 4: P3-10.1186\/gb-2003-4-5-p3.","journal-title":"Genome Biol"},{"key":"2927_CR31","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1038\/nprot.2008.211","volume":"4","author":"W Huang da","year":"2009","unstructured":"Huang da W, Sherman BT, Lempicki RA: Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc. 2009, 4: 44-57.","journal-title":"Nat Protoc"},{"key":"2927_CR32","doi-asserted-by":"publisher","first-page":"5158","DOI":"10.1158\/1078-0432.CCR-07-4756","volume":"14","author":"C Desmedt","year":"2008","unstructured":"Desmedt C, Haibe-Kains B, Wirapati P, Buyse M, Larsimont D, Bontempi G, Delorenzi M, Piccart M, Sotiriou C: Biological processes associated with breast cancer clinical outcome depend on the molecular subtypes. Clin Cancer Res. 2008, 14: 5158-5165. 10.1158\/1078-0432.CCR-07-4756.","journal-title":"Clin Cancer Res"},{"key":"2927_CR33","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1093\/intimm\/2.2.113","volume":"2","author":"NJ Stam","year":"1990","unstructured":"Stam NJ, Vroom TM, Peters PJ, Pastoors EB, Ploegh HL: HLA-A- and HLA-B-specific monoclonal antibodies reactive with free heavy chains in western blots, in formalin-fixed, paraffin-embedded tissue sections and in cryo-immuno-electron microscopy. Int Immunol. 1990, 2: 113-125. 10.1093\/intimm\/2.2.113.","journal-title":"Int Immunol"},{"key":"2927_CR34","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.4049\/jimmunol.137.7.2299","volume":"137","author":"NJ Stam","year":"1986","unstructured":"Stam NJ, Spits H, Ploegh HL: Monoclonal antibodies raised against denatured HLA-B locus heavy chains permit biochemical characterization of certain HLA-C locus products. J Immunol. 1986, 137: 2299-2306.","journal-title":"J Immunol"},{"key":"2927_CR35","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1002\/(SICI)1096-9926(199811)58:5<174::AID-TERA3>3.0.CO;2-Q","volume":"58","author":"LA Stanley","year":"1998","unstructured":"Stanley LA, Copp AJ, Pope J, Rolls S, Smelt V, Perry VH, Sim E: Immunochemical detection of arylamine N-acetyltransferase during mouse embryonic development and in adult mouse brain. Teratology. 1998, 58: 174-182. 10.1002\/(SICI)1096-9926(199811)58:5<174::AID-TERA3>3.0.CO;2-Q.","journal-title":"Teratology"},{"key":"2927_CR36","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1177\/44.9.8773572","volume":"44","author":"LA Stanley","year":"1996","unstructured":"Stanley LA, Coroneos E, Cuff R, Hickman D, Ward A, Sim E: Immunochemical detection of arylamine N-acetyltransferase in normal and neoplastic bladder. J Histochem Cytochem. 1996, 44: 1059-1067. 10.1177\/44.9.8773572.","journal-title":"J Histochem Cytochem"},{"key":"2927_CR37","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.1093\/bioinformatics\/btl117","volume":"22","author":"R Suzuki","year":"2006","unstructured":"Suzuki R, Shimodaira H: Pvclust: an R package for assessing the uncertainty in hierarchical clustering. Bioinformatics. 2006, 22: 1540-1542. 10.1093\/bioinformatics\/btl117.","journal-title":"Bioinformatics"},{"key":"2927_CR38","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan D, Weinberg RA: Hallmarks of cancer: the next generation. Cell. 2011, 144: 646-674. 10.1016\/j.cell.2011.02.013.","journal-title":"Cell"},{"key":"2927_CR39","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1038\/nrc2826","volume":"10","author":"N Shah","year":"2010","unstructured":"Shah N, Sukumar S: The Hox genes and their roles in oncogenesis. Nat Rev Cancer. 2010, 10: 361-371. 10.1038\/nrc2826.","journal-title":"Nat Rev Cancer"},{"key":"2927_CR40","doi-asserted-by":"publisher","first-page":"9527","DOI":"10.1158\/0008-5472.CAN-05-4470","volume":"66","author":"X Wu","year":"2006","unstructured":"Wu X, Chen H, Parker B, Rubin E, Zhu T, Lee JS, Argani P, Sukumar S: HOXB7, a homeodomain protein, is overexpressed in breast cancer and confers epithelial-mesenchymal transition. Cancer Res. 2006, 66: 9527-9534. 10.1158\/0008-5472.CAN-05-4470.","journal-title":"Cancer Res"},{"key":"2927_CR41","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1038\/modpathol.2011.174","volume":"25","author":"R Kornegoor","year":"2012","unstructured":"Kornegoor R, Verschuur-Maes AH, Buerger H, Hogenes MC, de Bruin PC, Oudejans JJ, van der Groep P, Hinrichs B, van Diest PJ: Molecular subtyping of male breast cancer by immunohistochemistry. Mod Pathol. 2012, 25: 398-404. 10.1038\/modpathol.2011.174.","journal-title":"Mod Pathol"},{"key":"2927_CR42","doi-asserted-by":"publisher","first-page":"R28","DOI":"10.1186\/bcr2258","volume":"11","author":"Y Ge","year":"2009","unstructured":"Ge Y, Sneige N, Eltorky MA, Wang Z, Lin E, Gong Y, Guo M: Immunohistochemical characterization of subtypes of male breast carcinoma. Breast Cancer Res. 2009, 11: R28-10.1186\/bcr2258.","journal-title":"Breast Cancer Res"},{"key":"2927_CR43","doi-asserted-by":"publisher","first-page":"R157","DOI":"10.1186\/gb-2007-8-8-r157","volume":"8","author":"AE Teschendorff","year":"2007","unstructured":"Teschendorff AE, Miremadi A, Pinder SE, Ellis IO, Caldas C: An immune response gene expression module identifies a good prognosis subtype in estrogen receptor negative breast cancer. Genome Biol. 2007, 8: R157-10.1186\/gb-2007-8-8-r157.","journal-title":"Genome Biol"},{"key":"2927_CR44","doi-asserted-by":"publisher","first-page":"R73","DOI":"10.1186\/bcr2138","volume":"10","author":"AE Teschendorff","year":"2008","unstructured":"Teschendorff AE, Caldas C: A robust classifier of high predictive value to identify good prognosis patients in ER-negative breast cancer. Breast Cancer Res. 2008, 10: R73-10.1186\/bcr2138.","journal-title":"Breast Cancer Res"},{"key":"2927_CR45","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.1200\/JCO.2009.22.8775","volume":"28","author":"J Staaf","year":"2010","unstructured":"Staaf J, Ringner M, Vallon-Christersson J, Jonsson G, Bendahl PO, Holm K, Arason A, Gunnarsson H, Hegardt C, Agnarsson BA, Luts L, Grabau D, Ferno M, Malmstrom PO, Johannsson OT, Loman N, Barkardottir RB, Borg A: Identification of subtypes in human epidermal growth factor receptor 2--positive breast cancer reveals a gene signature prognostic of outcome. J Clin Oncol. 2010, 28: 1813-1820. 10.1200\/JCO.2009.22.8775.","journal-title":"J Clin Oncol"},{"key":"2927_CR46","volume-title":"Breast Cancer Res Treat","author":"AM Shaaban","year":"2011","unstructured":"Shaaban AM, Ball GR, Brannan RA, Cserni G, Benedetto AD, Dent J, Fulford L, Honarpisheh H, Jordan L, Jones JL, Kanthan R, Maraqa L, Litwiniuk M, Mottolese M, Pollock S, Provenzano E, Quinlan PR, Reall G, Shousha S, Stephens M, Verghese ET, Walker RA, Hanby AM, Speirs V: A comparative biomarker study of 514 matched cases of male and female breast cancer reveals gender-specific biological differences. Breast Cancer Res Treat. 2011,"},{"key":"2927_CR47","volume-title":"Proc Natl Acad Sci USA","author":"K Jin","year":"2011","unstructured":"Jin K, Kong X, Shah T, Penet MF, Wildes F, Sgroi DC, Ma XJ, Huang Y, Kallioniemi A, Landberg G, Bieche I, Wu X, Lobie PE, Davidson NE, Bhujwalla ZM, Zhu T, Sukumar S: The HOXB7 protein renders breast cancer cells resistant to tamoxifen through activation of the EGFR pathway. Proc Natl Acad Sci USA. 2011,"},{"key":"2927_CR48","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/s10549-007-9632-6","volume":"109","author":"RC Millikan","year":"2008","unstructured":"Millikan RC, Newman B, Tse CK, Moorman PG, Conway K, Dressler LG, Smith LV, Labbok MH, Geradts J, Bensen JT, Jackson S, Nyante S, Livasy C, Carey L, Earp HS, Perou CM: Epidemiology of basal-like breast cancer. Breast Cancer Res Treat. 2008, 109: 123-139. 10.1007\/s10549-007-9632-6.","journal-title":"Breast Cancer Res Treat"},{"key":"2927_CR49","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1002\/1097-0215(20001120)89:6<500::AID-IJC6>3.0.CO;2-#","volume":"89","author":"I Gudmundsdottir","year":"2000","unstructured":"Gudmundsdottir I, Gunnlaugur Jonasson J, Sigurdsson H, Olafsdottir K, Tryggvadottir L, Ogmundsdottir HM: Altered expression of HLA class I antigens in breast cancer: association with prognosis. Int J Cancer. 2000, 89: 500-505. 10.1002\/1097-0215(20001120)89:6<500::AID-IJC6>3.0.CO;2-#.","journal-title":"Int J Cancer"},{"key":"2927_CR50","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1126\/science.7863341","volume":"267","author":"K Karre","year":"1995","unstructured":"Karre K: Express yourself or die: peptides, MHC molecules, and NK cells. Science. 1995, 267: 978-979. 10.1126\/science.7863341.","journal-title":"Science"},{"key":"2927_CR51","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/S0167-5699(96)10075-X","volume":"18","author":"F Garrido","year":"1997","unstructured":"Garrido F, Ruiz-Cabello F, Cabrera T, Perez-Villar JJ, Lopez-Botet M, Duggan-Keen M, Stern PL: Implications for immunosurveillance of altered HLA class I phenotypes in human tumours. Immunol Today. 1997, 18: 89-95. 10.1016\/S0167-5699(96)10075-X.","journal-title":"Immunol Today"},{"key":"2927_CR52","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1002\/gcc.20512","volume":"47","author":"L Wakefield","year":"2008","unstructured":"Wakefield L, Robinson J, Long H, Ibbitt JC, Cooke S, Hurst HC, Sim E: Arylamine N-acetyltransferase 1 expression in breast cancer cell lines: a potential marker in estrogen receptor-positive tumors. Genes Chromosomes Cancer. 2008, 47: 118-126. 10.1002\/gcc.20512.","journal-title":"Genes Chromosomes Cancer"},{"key":"2927_CR53","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1677\/erc.1.01120","volume":"13","author":"S Tozlu","year":"2006","unstructured":"Tozlu S, Girault I, Vacher S, Vendrell J, Andrieu C, Spyratos F, Cohen P, Lidereau R, Bieche I: Identification of novel genes that co-cluster with estrogen receptor alpha in breast tumor biopsy specimens, using a large-scale real-time reverse transcription-PCR approach. Endocr Relat Cancer. 2006, 13: 1109-1120. 10.1677\/erc.1.01120.","journal-title":"Endocr Relat Cancer"},{"key":"2927_CR54","first-page":"826","volume":"1","author":"PJ Adam","year":"2003","unstructured":"Adam PJ, Berry J, Loader JA, Tyson KL, Craggs G, Smith P, De Belin J, Steers G, Pezzella F, Sachsenmeir KF, Stamps AC, Herath A, Sim E, O'Hare MJ, Harris AL, Terrett JA: Arylamine N-acetyltransferase-1 is highly expressed in breast cancers and conveys enhanced growth and resistance to etoposide in vitro. Mol Cancer Res. 2003, 1: 826-835.","journal-title":"Mol Cancer Res"},{"key":"2927_CR55","doi-asserted-by":"publisher","first-page":"6459","DOI":"10.1158\/1078-0432.CCR-06-1383","volume":"12","author":"M Dolled-Filhart","year":"2006","unstructured":"Dolled-Filhart M, Ryden L, Cregger M, Jirstrom K, Harigopal M, Camp RL, Rimm DL: Classification of breast cancer using genetic algorithms and tissue microarrays. Clin Cancer Res. 2006, 12: 6459-6468. 10.1158\/1078-0432.CCR-06-1383.","journal-title":"Clin Cancer Res"},{"key":"2927_CR56","doi-asserted-by":"publisher","first-page":"R252","DOI":"10.1186\/bcr784","volume":"6","author":"I Bieche","year":"2004","unstructured":"Bieche I, Girault I, Urbain E, Tozlu S, Lidereau R: Relationship between intratumoral expression of genes coding for xenobiotic-metabolizing enzymes and benefit from adjuvant tamoxifen in estrogen receptor alpha-positive postmenopausal breast carcinoma. Breast Cancer Res. 2004, 6: R252-263. 10.1186\/bcr784.","journal-title":"Breast Cancer Res"},{"key":"2927_CR57","doi-asserted-by":"publisher","first-page":"22131","DOI":"10.1074\/jbc.M312858200","volume":"279","author":"NJ Butcher","year":"2004","unstructured":"Butcher NJ, Arulpragasam A, Minchin RF: Proteasomal degradation of N-acetyltransferase 1 is prevented by acetylation of the active site cysteine: a mechanism for the slow acetylator phenotype and substrate-dependent down-regulation. J Biol Chem. 2004, 279: 22131-22137. 10.1074\/jbc.M312858200.","journal-title":"J Biol Chem"}],"container-title":["Breast Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/bcr3116.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/bcr3116\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/bcr3116.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,8]],"date-time":"2024-10-08T10:51:21Z","timestamp":1728384681000},"score":1,"resource":{"primary":{"URL":"https:\/\/breast-cancer-research.biomedcentral.com\/articles\/10.1186\/bcr3116"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,2,14]]},"references-count":57,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2012,2]]}},"alternative-id":["2927"],"URL":"https:\/\/doi.org\/10.1186\/bcr3116","relation":{},"ISSN":["1465-542X"],"issn-type":[{"value":"1465-542X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,2,14]]},"assertion":[{"value":"4 August 2011","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 January 2012","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 February 2012","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 February 2012","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"R31"}}